Together with TMEM140, TEAD2, OR1J2, and GRIN2B, many other genes were commonly mutated across the tumor samples, however the recurrence always occurred when examining multiple metastatic samples of the same individual (T07–11 or T04–05 corresponding respectively to patients P06 and P04). This evidence concerns the gene GRIN2B and neoplasm.